Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

98 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
FFCD 1709-SIRTCI phase II trial: Selective internal radiation therapy plus Xelox, Bevacizumab and Atezolizumab in liver-dominant metastatic colorectal cancer.
Randrian V, Pernot S, Le Malicot K, Catena V, Baumgaertner I, Tacher V, Forestier J, Hautefeuille V, Tabouret-Viaud C, Gagnaire A, Mitry E, Guiu B, Aparicio T, Smith D, Dhomps A, Tasu JP, Perdrisot R, Edeline J, Capron C, Cheze-Le Rest C, Emile JF, Laurent-Puig P, Bejan-Angoulvant T, Sokol H, Lepage C, Taieb J, Tougeron D. Randrian V, et al. Among authors: bejan angoulvant t. Dig Liver Dis. 2022 Jul;54(7):857-863. doi: 10.1016/j.dld.2022.04.024. Epub 2022 May 21. Dig Liver Dis. 2022. PMID: 35610167 Free article. Clinical Trial.
A novel way to manage trastuzumab cardiotoxicity.
Hamdan D, Darrouzain F, Bejan-Angoulvant T, Isorni C, Zelek L, Paintaud G, Janin A, Bousquet G. Hamdan D, et al. Cancer Chemother Pharmacol. 2018 Apr;81(4):791-796. doi: 10.1007/s00280-018-3555-2. Epub 2018 Mar 1. Cancer Chemother Pharmacol. 2018. PMID: 29497813
Pharmacokinetics of adalimumab in Crohn's disease.
Ternant D, Karmiris K, Vermeire S, Desvignes C, Azzopardi N, Bejan-Angoulvant T, van Assche G, Paintaud G. Ternant D, et al. Eur J Clin Pharmacol. 2015 Sep;71(9):1155-7. doi: 10.1007/s00228-015-1892-1. Epub 2015 Jun 27. Eur J Clin Pharmacol. 2015. PMID: 26115613 Free article. No abstract available.
Letter to Dreesen et al. on their article "Modelling of the Relationship Between Infliximab Exposure, Faecal Calprotectin, and Endoscopic Remission in Patients With Crohn's Disease"-A comprehensive review of infliximab population pharmacokinetic modelling publications.
Le Tilly O, Bejan-Angoulvant T, Paintaud G, Ternant D. Le Tilly O, et al. Br J Clin Pharmacol. 2021 Mar;87(3):1594-1595. doi: 10.1111/bcp.14554. Epub 2020 Dec 2. Br J Clin Pharmacol. 2021. PMID: 33269471 Free article. No abstract available.
98 results